IDO1 and ovarian carcinoma: Unexpectedly, in an IDO1 positive ovarian cancer cell line, Indoximod triggered an increased IFNγ-induced release of the TRP metabolite KYN concurrent with an increase of IDO1 mRNA (25) indicating an activation of KP instead of anticipated inhibition.